ARCHIVES

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

This article is from The Cancer Letter archive.

Vol. 01 No. 38 | September 19, 1975

Download PDF Visit The Full Archive

Related Articles

In Brief: NIDDK Begins BPH Trial; Roswell Park Honors Schwarzkopf; NRC Cites MIT

March 1, 1996

Lower Dose Dexamethasone Can Be Used To Treat Newly Diagnosed Myeloma

November 27, 2009

Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy

June 27, 2014

NCI Cooperative Group, Cancer Center Trials Listed

November 25, 2005

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

In Brief: Six On NCA Serve Out Terms, No Successors in Sights DCBD Renamed With ‘Centers’ In Title

February 9, 1990